Major Tranquilizers Market - Global Outlook and Forecast 2022-2028

Major Tranquilizers Market - Global Outlook and Forecast 2022-2028

  • Market Monitor Global
  • January 2022
  • Pharmaceutical
  • 74 pages

Report Description

Major tranquilizers are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
This report contains market size and forecasts of Major Tranquilizers in global, including the following market information:
Global Major Tranquilizers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Major Tranquilizers Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Major Tranquilizers companies in 2021 (%)
The global Major Tranquilizers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Major Tranquilizers include Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Major Tranquilizers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Major Tranquilizers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Major Tranquilizers Market Segment Percentages, by Type, 2021 (%)
First Generation
Second Generation
Third Generation
Global Major Tranquilizers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Major Tranquilizers Market Segment Percentages, by Application, 2021 (%)
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Global Major Tranquilizers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Major Tranquilizers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Major Tranquilizers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Major Tranquilizers revenues share in global market, 2021 (%)
Key companies Major Tranquilizers sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Major Tranquilizers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan

Have query on this report?

Make an Enquiry
1 Introduction to Research & Analysis Reports
1.1 Major Tranquilizers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
List of Tables
Table 1. Key Players of Major Tranquilizers in Global Market
Table 2. Top Major Tranquilizers Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Major Tranquilizers Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Major Tranquilizers Revenue Share by Companies, 2017-2022
Table 5. Global Major Tranquilizers Sales by Companies, (K MT), 2017-2022

Success Stories

Our Clients